Cargando…
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
Tumour-infiltrating immune cells are a source of important prognostic information for patients with resectable colon cancer. We developed a novel immune model based on systematic assessments of the immune landscape inferred from bulk tumor transcriptomes of stage I–III colon cancer patients. The “Ce...
Autores principales: | Zhou, Rui, Zhang, Jingwen, Zeng, Dongqiang, Sun, Huiying, Rong, Xiaoxiang, Shi, Min, Bin, Jianping, Liao, Yulin, Liao, Wangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426802/ https://www.ncbi.nlm.nih.gov/pubmed/30564892 http://dx.doi.org/10.1007/s00262-018-2289-7 |
Ejemplares similares
-
A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2019) -
A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer
por: Zhou, Rui, et al.
Publicado: (2020) -
Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer
por: Zhou, Rui, et al.
Publicado: (2022) -
Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes
por: Zhou, Rui, et al.
Publicado: (2022) -
CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy
por: Sun, Huiying, et al.
Publicado: (2021)